Immune-Related Adverse Events in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy with Pembrolizumab: What Needs to Be Managed Before Surgery.
Saved in:
| Title: | Immune-Related Adverse Events in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy with Pembrolizumab: What Needs to Be Managed Before Surgery. |
|---|---|
| Authors: | Lee, Jeeyeon1 (AUTHOR), Kang, Byeongju1,2 (AUTHOR), Moon, Joon Suk1,3 (AUTHOR), Um, Taegyu1 (AUTHOR), Choi, Jung Eun2 (AUTHOR), Lee, Moohyun3 (AUTHOR), Chae, Yee Soo1 (AUTHOR), Lee, Soo Jung1,2 (AUTHOR), Lee, In Hee1 (AUTHOR), Kang, Su Hwan2 (AUTHOR), Koh, Sung Ae2 (AUTHOR), Kang, Sun Hee3 (AUTHOR), Park, Keon Uk3 (AUTHOR), Kim, Hyera3 (AUTHOR), Park, Ho Yong1 (AUTHOR) phy123@knu.ac.kr |
| Source: | Cancers. Mar2026, Vol. 18 Issue 6, p919. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers18060919 |
